Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44

doi:10.1084/jem.177.4.897

This Article

Full Text (PDF, 1442K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Koopman, G.

Articles by Pals, S. T.

Search for Related Content

PubMed

PubMed Citation

Articles by Koopman, G.

Articles by Pals, S. T.

Pubmed/NCBI databases

Compound via MeSH
Substance via MeSH

Social Bookmarking

What's this?

ARTICLES

Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44

G Koopman, KH Heider, E Horst, GR Adolf, F van den Berg, H Ponta, P Herrlich and ST Pals
Department of Pathology, Academic Medical Center, University of Amsterdam, The Netherlands.

A recently described splice variant of CD44 expressed in metastasizing cell lines of rat tumors, has been shown to confer metastatic potential to nonmetastasizing rat pancreatic carcinoma and sarcoma cell lines. Using antibodies raised against a bacterial fusion protein encoded by variant CD44 sequences, we have explored the expression of variant CD44 glycoproteins on human lymphoid cells and tissues and on non-Hodgkin's lymphomas. Normal lymphohematopoietic cells express barely detectable low levels of variant CD44 glycoproteins, whereas T lymphocytes, upon activation by mitogen or antigen, transiently upregulate expression of specific CD44 variant glycoproteins. The reaction pattern of various antibodies indicates that these CD44 variants contain the domain encoded by exon v6, which is part of the variant that in the rat confers metastatic capability. It is interesting that overexpression of v6 was also found in several aggressive, but not low-grade, non- Hodgkin's lymphomas.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Xie, Y., Chan, H., Fan, J., Chen, Y., Young, J., Li, W., Miao, X., Yuan, Z., Wang, H., Tam, P. K.H., Ren, Y. (2007). Involvement of visinin-like protein-1 (VSNL-1) in regulating proliferative and invasive properties of neuroblastoma. Carcinogenesis 28: 2122-2130 [Abstract] [Full Text]
Lossos, I. S., Morgensztern, D. (2006). Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma. JCO 24: 995-1007 [Abstract] [Full Text]
Alam, T. N., O'Hare, M. J., Laczko, I., Freeman, A., Al-Beidh, F., Masters, J. R., Hudson, D. L. (2004). Differential Expression of CD44 During Human Prostate Epithelial Cell Differentiation. J. Histochem. Cytochem. 52: 1083-1090 [Abstract] [Full Text]
Huang, R., Xing, Z., Luan, Z., Wu, T., Wu, X., Hu, G. (2003). A Specific Splicing Variant of SVH, a Novel Human Armadillo Repeat Protein, Is Up-Regulated in Hepatocellular Carcinomas. Cancer Res. 63: 3775-3782 [Abstract] [Full Text]
Brown, K. L., Maiti, A., Johnson, P. (2001). Role of Sulfation in CD44-Mediated Hyaluronan Binding Induced by Inflammatory Mediators in Human CD14+ Peripheral Blood Monocytes. J. Immunol. 167: 5367-5374 [Abstract] [Full Text]
Wibulswas, A., Croft, D., Bacarese-Hamilton, I., McIntyre, P., Genot, E., Kramer, I. M. (2000). The CD44v7/8 Epitope as a Target to Restrain Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis. Am. J. Pathol. 157: 2037-2044 [Abstract] [Full Text]
Wielenga, V. J. M., van der Voort, R., Taher, T. E. I., Smit, L., Beuling, E. A., van Krimpen, C., Spaargaren, M., Pals, S. T. (2000). Expression of c-Met and Heparan-Sulfate Proteoglycan Forms of CD44 in Colorectal Cancer. Am. J. Pathol. 157: 1563-1573 [Abstract] [Full Text]
Drillenburg, P., Pals, S. T. (2000). Cell adhesion receptors in lymphoma dissemination. Blood 95: 1900-1910 [Abstract] [Full Text]
Jones, M., Tussey, L., Athanasou, N., Jackson, D. G. (2000). Heparan Sulfate Proteoglycan Isoforms of the CD44 Hyaluronan Receptor Induced in Human Inflammatory Macrophages Can Function as Paracrine Regulators of Fibroblast Growth Factor Action. J. Biol. Chem. 275: 7964-7974 [Abstract] [Full Text]
Seiter, S., Schmidt, D.-S., Zoller, M. (2000). The CD44 variant isoforms CD44v6 and CD44v7 are expressed by distinct leukocyte subpopulations and exert non-overlapping functional activities. Int Immunol 12: 37-49 [Abstract] [Full Text]
Protin, U., Schweighoffer, T., Jochum, W., Hilberg, F. (1999). CD44-Deficient Mice Develop Normally with Changes in Subpopulations and Recirculation of Lymphocyte Subsets. J. Immunol. 163: 4917-4923 [Abstract] [Full Text]
van der Voort, R., Taher, T. E.�I., Wielenga, V. J.�M., Spaargaren, M., Prevo, R., Smit, L., David, G., Hartmann, G., Gherardi, E., Pals, S. T. (1999). Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met. J. Biol. Chem. 274: 6499-6506 [Abstract] [Full Text]
Wielenga, V. J. M., Smits, R., Korinek, V., Smit, L., Kielman, M., Fodde, R., Clevers, H., Pals, S. T. (1999). Expression of CD44 in Apc and Tcf Mutant Mice Implies Regulation by the WNT Pathway. Am. J. Pathol. 154: 515-523 [Abstract] [Full Text]
Martegani, M. P., Del Prete, F., Gasbarri, A., Natali, P. G., Bartolazzi, A. (1999). Structural Variability of CD44v Molecules and Reliability of Immunodetection of CD44 Isoforms Using mAbs Specific for CD44 Variant Exon Products. Am. J. Pathol. 154: 291-300 [Abstract] [Full Text]
Goodison, S., Yoshida, K., Churchman, M., Tarin, D. (1998). Multiple Intron Retention Occurs in Tumor Cell CD44 mRNA Processing. Am. J. Pathol. 153: 1221-1228 [Abstract] [Full Text]
Reinisch, W, Heider, K-H, Oberhuber, G, Dejaco, C, Mullner, M, Adolf, G R, Gasche, C (1998). Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease. Gut 43: 375-382 [Abstract] [Full Text]
Roca, X., Mate, J. L., Ariza, A., Munoz-Marmol, A. M., von Uexkull-Guldeband, C., Pellicer, I., Navas-Palacios, J. J., Isamat, M. (1998). CD44 Isoform Expression Follows Two Alternative Splicing Pathways in Breast Tissue. Am. J. Pathol. 153: 183-190 [Abstract] [Full Text]
Rachmilewitz, J., Tykocinski, M. L. (1998). Differential Effects of Chondroitin Sulfates A and B on Monocyte and B-Cell Activation: Evidence for B-Cell Activation Via a CD44-Dependent Pathway. Blood 92: 223-229 [Abstract] [Full Text]
Yakushijin, Y., Steckel, J., Kharbanda, S., Hasserjian, R., Neuberg, D., Jiang, W.-m., Anderson, I., Shipp, M. A. (1998). A Directly Spliced Exon 10-Containing CD44 Variant Promotes the Metastasis and Homotypic Aggregation of Aggressive Non-Hodgkin's Lymphoma. Blood 91: 4282-4291 [Abstract] [Full Text]
Legras, S., Gunthert, U., Stauder, R., Curt, F., Oliferenko, S., Kluin-Nelemans, H.C., Marie, J.P., Proctor, S., Jasmin, C., Smadja-Joffe, F. (1998). A Strong Expression of CD44-6v Correlates With Shorter Survival of Patients With Acute Myeloid Leukemia. Blood 91: 3401-3413 [Abstract] [Full Text]
Sleeman, J. P., Kondo, K., Moll, J., Ponta, H., Herrlich, P. (1997). Variant Exons v6 and v7 Together Expand the Repertoire of Glycosaminoglycans Bound by CD44. J. Biol. Chem. 272: 31837-31844 [Abstract] [Full Text]
Schmits, R., Filmus, J., Gerwin, N., Senaldi, G., Kiefer, F., Kundig, T., Wakeham, A., Shahinian, A., Catzavelos, C., Rak, J., Furlonger, C., Zakarian, A., Simard, J. J.L., Ohashi, P. S., Paige, C. J., Gutierrez-Ramos, J. C., Mak, T. W. (1997). CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity. Blood 90: 2217-2233 [Abstract] [Full Text]
Griffioen, A. W., Coenen, M. J.H., Damen, C. A., Hellwig, S. M.M., H.J. van Weering, D., Vooys, W., Blijham, G. H., Groenewegen, G. (1997). CD44 Is Involved in Tumor Angiogenesis; an Activation Antigen on Human Endothelial Cells. Blood 90: 1150-1159 [Abstract] [Full Text]
Weiss, J. M., Sleeman, J., Renkl, A. C., Dittmar, H., Termeer, C. C., Taxis, S., Howells, N., Hofmann, M., Kohler, G., Schopf, E., Ponta, H., Herrlich, P., Simon, J. C. (1997). An Essential Role for CD44 Variant Isoforms in Epidermal Langerhans Cell and Blood Dendritic Cell Function. JCB 137: 1137-1147 [Abstract] [Full Text]
Zhu, S.-N., Nolle, B., Duncker, G. (1997). Expression of adhesion molecule CD44 on human corneas. Br J Ophthalmol 81: 80-84 [Abstract] [Full Text]
Taher, T. E. I., Smit, L., Griffioen, A. W., Schilder-Tol, E. J. M., Borst, J., Pals, S. T. (1996). Signaling through CD44 Is Mediated by Tyrosine Kinases. J. Biol. Chem. 271: 2863-2867 [Abstract] [Full Text]
Neame, S., Uff, C., Sheikh, H, Wheatley, S., Isacke, C. (1995). CD44 exhibits a cell type dependent interaction with triton X-100 insoluble, lipid rich, plasma membrane domains. J. Cell Sci. 108: 3127-3135 [Abstract]
Hudson, D., Sleeman, J, Watt, F. (1995). CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J. Cell Sci. 108: 1959-1970 [Abstract]
Favrot, M.C., Combaret, V., Lasset, C. (1993). CD44 -- A New Prognostic Marker for Neuroblastoma. NEJM 329: 1965-1965 [Full Text]
van Weering, D H, Baas, P D, Bos, J L (1993). A PCR-based method for the analysis of human CD44 splice products.. Genome Res 3: 100-106 [Abstract]
Matter, N., Marx, M., Weg-Remers, S., Ponta, H., Herrlich, P., Konig, H. (2000). Heterogeneous Ribonucleoprotein A1 Is Part of an Exon-specific Splice-silencing Complex Controlled by Oncogenic Signaling Pathways. J. Biol. Chem. 275: 35353-35360 [Abstract] [Full Text]